Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

NCT05272462 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Minoxidil

Sponsor

Loyola University

Collaborators

[object Object]
[object Object]